The immunotherapy of cancer requires the definition of a suitable targ
et for and the induction of a CD8(+) cytoxic lymphocyte reaction. In b
reast cancer, particularly mucins (MUCl) of the variable number of tan
dem repeat sequence may be a suitable target but there has been a prob
lem in inducing a cytotoxic response. MUCl peptides, conjugated to car
riers (keyhole-limpet hemocyanin or diphtheria toxoid) induce a humora
l response and give poor tumor protection in mice and there is little
cellular immunity. However, when MUCl fusion protein is conjugated to
mannan under oxidizing conditions, a cellular immune response in induc
ed, with significant tumor protection, cytotoxic T lymphocytes and lit
tle antibody. The procedure may also be useful for other antigens. Cop
yright (C) 1996 Elsevier Science Ltd.